Fundraising Fox

Sarepta Therapeutics

Cambridge, US · 2 known investors

sarepta.com ↗

Sarepta develops precision genetic medicines for people with rare diseases, with a focus on rare neuromuscular conditions. The company also runs an investigator-initiated studies program that funds independent clinical and non-clinical research in its therapeutic areas.

BiotechHealthtechin /sarepta-therapeutics@sarepta

Founders & leadership

WC
WILLIAM CIAMBRONEExecutive Officer
HW
HANS WIGZELLDirector
CN
CLAUDE NICAISEDirector
DS
DOUGLAS S. INGRAMExecutive Officer, Director
DT
DAVID TYRONNE HOWTONExecutive Officer
MA
MARY ANN GRAYDirector
SM
SANDESH MAHATMEExecutive Officer
GO
GILMORE O'NEILLExecutive Officer
MK
M. KATHLEEN BEHRENSDirector
RJ
RICHARD J. BARRYDirector
MW
MICHAEL W. BONNEYDirector
AC
ALEXANDER CUMBOExecutive Officer

Investors · 2

Avoro Capital AdvisorsNew York
Roche Venture FundBasel · $648K – $3.2M

Reported raises · per SEC filings

Form D private placements
▶$400MraisedFeb 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MICHAEL W. BONNEYDirector
  • MARY ANN GRAYDirector
  • CLAUDE NICAISEDirector
  • HANS WIGZELLDirector
  • JOHN C. MARTINDirector
  • DOUGLAS S. INGRAMExecutive Officer, Director
  • ALEXANDER CUMBOExecutive Officer
  • DAVID TYRONNE HOWTONExecutive Officer
  • SANDESH MAHATMEExecutive Officer
  • GILMORE O'NEILLExecutive Officer
  • WILLIAM CIAMBRONEExecutive Officer
  • M. KATHLEEN BEHRENSDirector
  • RICHARD J. BARRYDirector
Offering amount
$400M
Amount sold
$400M
First sale
Feb 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30.5MraisedNov 2019 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • WILLIAM CIAMBRONEExecutive Officer
  • HANS WIGZELLDirector
  • CLAUDE NICAISEDirector
  • DOUGLAS S. INGRAMExecutive Officer, Director
  • DAVID TYRONNE HOWTONExecutive Officer
  • MARY ANN GRAYDirector
  • SANDESH MAHATMEExecutive Officer
  • GILMORE O'NEILLExecutive Officer
  • M. KATHLEEN BEHRENSDirector
  • RICHARD J. BARRYDirector
  • MICHAEL W. BONNEYDirector
  • ALEXANDER CUMBOExecutive Officer
Offering amount
$30.5M
Amount sold
$30.5M
First sale
Nov 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.